Literature DB >> 10616194

Crosslinking of CD44 on rheumatoid synovial cells augment interleukin 6 production.

K Fujii1, Y Tanaka, S Hübscher, K Saito, T Ota, S Eto.   

Abstract

CD44 is a ubiquitous molecule also known as hyaluronic acid or homing receptor. However, its cellular functions and its role in inflammation, for example rheumatoid synovitis, are currently unknown. Here we propose a novel function for CD44. Using synovial cells from patients with rheumatoid arthritis (RA), we demonstrated that CD44 crosslinking and binding to hyaluronan augmented IL-6 production. Briefly, we found that (a) rheumatoid synovial cells highly expressed CD44; (b) crosslinking of CD44 augmented IL-6 production and its mRNA transcription; (c) hyaluronan, especially when fragmented, also increased IL-6 production; and (d) CD44 activated the transcription factor activator protein-1 and CAMP-responsive element binding protein. These results indicate that the adhesion of RA synovial cells to matrices such as hyaluronic acid through CD44 could activate transcription factor, resulting in cytokine production. We therefore propose that the function of adhesion molecules as a signaling molecule may be pivotal in the pathogenesis of inflammation, including RA synovitis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10616194

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  2 in total

1.  The hyaluronan receptor for endocytosis (HARE) activates NF-κB-mediated gene expression in response to 40-400-kDa, but not smaller or larger, hyaluronans.

Authors:  Madhu S Pandey; Bruce A Baggenstoss; Jennifer Washburn; Edward N Harris; Paul H Weigel
Journal:  J Biol Chem       Date:  2013-03-24       Impact factor: 5.157

2.  Small GTP-binding protein Rho-mediated signaling promotes proliferation of rheumatoid synovial fibroblasts.

Authors:  Shingo Nakayamada; Hitoshi Kurose; Kazuyoshi Saito; Akira Mogami; Yoshiya Tanaka
Journal:  Arthritis Res Ther       Date:  2005-02-18       Impact factor: 5.156

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.